Literature DB >> 7068230

[Fosfomycin concentrations in serum and bile (author's transl)].

O Müller, U Rückert, W Walter, R Haag, W Sauer.   

Abstract

40 patients were given a single, short intravenous infusion of 4 g fosfomycin over a period of five to ten minutes. In 23 patients, the contents of the gall bladder were removed intra-operatively 30-105 minutes after the fosfomycin infusion. In 17 patients who had undergone cholecystectomy eight to ten days earlier, bile was obtained via a T-drain 30, 60, 120, 240 and 360 minutes after the fosfomycin infusion. Fosfomycin concentrations of 1-196 mg/l were present in the bile which had been removed intra-operatively. No correlation was found between the concentration and the time of removal. Patients with the highest alkaline phosphatase in serum, however, had the lowest fosfomycin concentrations. In the patients with T-drains, the highest concentrations (93 mg/l) were found 30 minutes after the fosfomycin infusion. By the sixth hour the concentrations had fallen to 19 mg/l.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068230     DOI: 10.1007/bf01640831

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Bacteriologic studies of biliary tract infection.

Authors:  R J Flemma; L M Flint; S Osterhout; W W Shingleton
Journal:  Ann Surg       Date:  1967-10       Impact factor: 12.969

2.  Pharmacokinetics of fosfomycin.

Authors:  W M Kirby
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

3.  Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum.

Authors:  M R Keighley; R B Drysdale; A H Quoraishi; D W Burdon; J Alexander-Willians
Journal:  Gut       Date:  1976-07       Impact factor: 23.059

4.  Fosfomycin: Laboratory studies.

Authors:  H B Woodruff; J M Mata; S Hernández; S Mochales; A Rodríguez; E O Stapley; H Wallick; A K Miller; D Hendlin
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

5.  In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.

Authors:  H Grimm
Journal:  Infection       Date:  1979       Impact factor: 3.553

  5 in total
  4 in total

Review 1.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 2.  Fosfomycin and nitrofurantoin: classic antibiotics and perspectives.

Authors:  Cristiane Dos Santos; Lucas Souza Dos Santos; Octávio Luiz Franco
Journal:  J Antibiot (Tokyo)       Date:  2021-07-09       Impact factor: 2.649

Review 3.  Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Authors:  Anneke Corinne Dijkmans; Natalia Veneranda Ortiz Zacarías; Jacobus Burggraaf; Johan Willem Mouton; Erik Bert Wilms; Cees van Nieuwkoop; Daniel Johannes Touw; Jasper Stevens; Ingrid Maria Catharina Kamerling
Journal:  Antibiotics (Basel)       Date:  2017-10-31

4.  Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens.

Authors:  Natalia V Ortiz Zacarías; Anneke C Dijkmans; Jacobus Burggraaf; Johan W Mouton; Erik B Wilms; Cees van Nieuwkoop; Daan J Touw; Ingrid M C Kamerling; Jasper Stevens
Journal:  Pharmacol Res Perspect       Date:  2018-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.